NCT00387426 2014-05-28Sunitinib in Treating Patients With Idiopathic MyelofibrosisNational Cancer Institute (NCI)Phase 2 Terminated14 enrolled 5 charts
NCT00398112 2014-05-14Sunitinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaNational Cancer Institute (NCI)Phase 2 Completed18 enrolled 9 charts
NCT00890747 2014-03-17Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyNational Cancer Institute (NCI)Phase 1 Completed42 enrolled